Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitroHighlights
With the development of the COVID-19 epidemic, there is an urgent need to establish a system for determining the effectiveness and neutralizing activity of vaccine candidates in biosafety level 2 (BSL-2) facilities. Previously, researchers had developed a pseudotyped virus system for SARS-CoV and ME...
Main Authors: | Ren Yang, Baoying Huang, Ruhan A, Wenhui Li, Wenling Wang, Yao Deng, Wenjie Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Biosafety and Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590053620300884 |
Similar Items
-
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
by: Yue Zheng, et al.
Published: (2021-01-01) -
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
by: Katharine H.D. Crawford, et al.
Published: (2020-05-01) -
Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus
by: Xinping Fu, et al.
Published: (2021-03-01) -
Comparison of Four SARS-CoV-2 Neutralization Assays
by: Lydia Riepler, et al.
Published: (2021-12-01) -
A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
by: Gaetano Donofrio, et al.
Published: (2021-04-01)